Clinical Trials Directory

Trials / Completed

CompletedNCT04394481

Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery

Extension of the Analgesia of an Interscalene Block of the Brachial Plexus by Combined Injection of Dexamethasone and Dexmedetomidine, After Arthroscopic Shoulder Surgery: Randomized, Controlled, Double-blind Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
122 (actual)
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of the study is to demonstrate the efficacy of Dexmedetomidine on the prolongation of analgesia obtained by interscalenic bloc of the brachial plexus and intravenous injection of Dexamethasone (efficacy objective).

Detailed description

This is an interventional, comparative, randomized, controlled study versus reference treatment, in 2 parallel groups, double blind (patient and evaluator), multicenter, aiming to demonstrate the superiority of This is an interventional, comparative, randomized, controlled study versus reference treatment, in 2 parallel groups, double blind (patient and evaluator), multicenter, aiming to demonstrate the superiority of Dexmedetomidine over the absence of Dexmedetomidine, in adjuvantation of a loco regional anesthesia (interscalenic bloc of the brachial plexus + intravenous injection of Dexamethasone), on the prolongation of the analgesia, following a surgery of the rotator cuff of the shoulder under arthroscopy. Patients will be randomized into 2 groups according to the treatment received: * Dexmedetomidine; * Nothing (control arm). The investigator (anesthesiologist) who will perform the randomization will not be blinded to the treatment.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineIV injection (1 µg/kg - 100 mL) before anesthetic induction
DRUGRopivacainePerinervous injection between C5 and C6 nerve roots / interscalene block (0.75% - 20 mL)
DRUGDexamethasoneIV injection (0.15 mg/kg) during anesthetic induction

Timeline

Start date
2020-09-28
Primary completion
2021-12-11
Completion
2021-12-11
First posted
2020-05-19
Last updated
2022-01-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04394481. Inclusion in this directory is not an endorsement.